Monday, February 23, 2026 | 02:00 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Page 7 - Pharma Sctors

Cabinet secy-led panel to take call on more allocation to PLI pharma

The department has urged the top government panel to provide additional funds of around Rs 3,000 crore under the scheme for pharmaceutical medicines

Cabinet secy-led panel to take call on more allocation to PLI pharma
Updated On : 23 Nov 2021 | 6:05 AM IST

Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore

The drug firm on Monday reported a decline in its consolidated net profit

Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
Updated On : 08 Nov 2021 | 10:05 PM IST

This SME pharma stock has zoomed 108% thus far in September

In past three months, Kwality Pharmaceuticals has zoomed 398 per cent, as compared to 12.8 per cent rise in the S&P BSE Sensex on the back of improved business outlook

This SME pharma stock has zoomed 108% thus far in September
Updated On : 29 Sep 2021 | 1:56 PM IST

ACC, Cipla: 66 stocks from Nifty 500 index are showing weakness on charts

Few pharma stocks are expected to weaken at higher levels.

ACC, Cipla: 66 stocks from Nifty 500 index are showing weakness on charts
Updated On : 11 Dec 2020 | 12:19 PM IST

Alembic Pharma sees domestic business growing in double digits this fiscal

Strong brand recall, an efficient sales force, a growing network of supportive doctors and timely product launches are the key catalysts for this business

Alembic Pharma sees domestic business growing in double digits this fiscal
Updated On : 12 Jul 2020 | 2:25 PM IST

Fortis Malar, Lal Path Labs: Diagnostic and healthcare stocks on the charts

Stocks of diagnostic chains and hospitals have been in focus as Covid-19 pandemic spread across the country. Is it a good strategy to stay put in these counters? Here's what the charts suggest

Fortis Malar, Lal Path Labs: Diagnostic and healthcare stocks on the charts
Updated On : 24 Jun 2020 | 11:38 AM IST

India may face shortage of drugs as supplies from Chinese companies dry up

Almost 60% of India's total bulk drug requirements are imported from China

India may face shortage of drugs as supplies from Chinese companies dry up
Updated On : 01 Oct 2018 | 5:30 AM IST